Dr. Hiu Chun Lam completed his Ph.D. at the University of Adelaide under the supervision of A/Prof. Jonathan George, followed by postdoctoral training at Peking University under Professor Xiaoguang Lei. In 2020, Hiu joined the Molecular Imaging and Therapy Research Unit (MITRU) at the South Australian Health and Medical Research Institute (SAHMRI) as a radiochemist. In MITRU, Hiu develops the manufacturing process of radioisotopes and radiopharmaceuticals for clinical trials and special access schemes. He is also leading several pre-clinical projects including drug discovery program for novel radiopharmaceuticals.
NIF is hiring: As the Scientific Project Manager, you will be instrumental in driving the successful delivery of key initiatives within the National Imaging Facility.
10 September 2024
Novel imaging methods combined with cognitive, genetic and medical data will use AI to increase the speed and accuracy of diagnoses and treatment for epilepsy patients, according to researchers workin
24 June 2024
10 April 2024
In a pioneering initiative, researchers aim to uncover signs of an often-missed condition in unborn babies (called ‘foetal growth restriction’) by adding magnetic resonance imaging (MRI) scans to
18 December 2023